Roadmap to Robotic Process Automation
Streamlining organization-wide business process automation initiatives and addressing process inefficiencies and bottlenecks are the key reasons for investing in RPA.
Source: informationweek.com
📰 Ted Kummert News
Ted Kummert News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ted Kummert. Real-time updates on events, politics, business and more.
Re:infer acquisition gives boost to UiPath's language processing abilities
Re:infer acquisition gives boost to UiPath's language processing abilities - SiliconANGLE
Source: siliconangle.com
UiPath Business Automation Platform Previews New Features to Support App Development, Expand Automation Use Cases
UiPath (NYSE: PATH), a leading enterprise automation software company, unveiled its latest platform updates that bring developer-friendly automation [...]
Javier Castellanos Ted Kummert Communications Mining Uipath Business Automation Platform Executive Vice President Robot Factory
Source: insidebigdata.com
Automation Leader UiPath Bolts On Text Mining Startup Re:infer
Robotic automation company UiPath acquires AI communications specialist Re:infer; picks up AI and NLP capabilities.
Source: slator.com
UiPath acquires Re:infer to expand its AI capabilities
UiPath acquires Re:infer to expand its AI capabilities - SiliconANGLE
Source: siliconangle.com
UiPath acquires London-based NLP startup Reinfer – TechCrunch
UiPath is one of the preeminent RPA platforms, helping to automate repetitive software-based tasks. It just acquired NLP startup Re:infer.
Source: techcrunch.com
UiPath (NASDAQ:PATH) PT Lowered to $40.00 at Needham & Company LLC
UiPath (NASDAQ:PATH – Get Rating) had its target price reduced by Needham & Company LLC from $85.00 to $40.00 in a research note released on Thursday morning, The Fly reports. They currently have a buy rating on the healthcare company’s stock. PATH has been the subject of a number of other research reports. Morgan Stanley […]
United States Kimberly Hammonds Ted Kummert Morgan Stanley Harbor Investment Advisory Berenberg Bank
Source: etfdailynews.com
UiPath (NASDAQ:PATH) PT Lowered to $57.50
UiPath (NASDAQ:PATH – Get Rating) had its target price cut by Credit Suisse Group from $75.00 to $57.50 in a research report report published on Thursday morning, The Fly reports. They currently have an outperform rating on the healthcare company’s stock. A number of other analysts have also issued reports on PATH. Morgan Stanley raised […]
United States Hitesh Ramani Thomson Reuter Ted Kummert Morgan Stanley Securities Exchange Commission
Source: etfdailynews.com
Canaccord Genuity Group Lowers UiPath (NASDAQ:PATH) Price Target to $30.00
UiPath (NASDAQ:PATH – Get Rating) had its price target lowered by investment analysts at Canaccord Genuity Group from $55.00 to $30.00 in a report released on Thursday, Benzinga reports. The firm presently has a “hold” rating on the healthcare company’s stock. Canaccord Genuity Group’s price objective points to a potential upside of 27.33% from the […]
United States Kimberly Hammonds Thomson Reuter Ted Kummert Morgan Stanley Securities Exchange Commission
Source: etfdailynews.com
Signaturefd LLC Increases Stock Position in UiPath Inc. (NASDAQ:PATH)
Signaturefd LLC raised its position in shares of UiPath Inc. (NASDAQ:PATH – Get Rating) by 564.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,560 shares of the healthcare company’s stock after buying an additional 3,024 shares during the quarter. Signaturefd LLC’s […]
Source: etfdailynews.com